Case Study: Sanofi achieves scalable, risk-based clinical trial data de-identification with Privacy Analytics

Sanofi de-identifies clinical trial data with Privacy Analytics for secondary research

Sanofi, a global pharmaceutical company, sought to share clinical trial data with researchers to advance medical science while addressing significant privacy concerns. They engaged vendor Privacy Analytics to implement a scalable, risk-based de-identification methodology for a vaccine clinical trial dataset.

Privacy Analytics provided its methodology and software to de-identify the clinical trial data. The project aimed to compare these results with Sanofi’s existing process and to inform the company's future de-identification strategy. This solution enabled Sanofi to maximize the utility of its data for secondary research opportunities while ensuring participant privacy was protected.

Sanofi